精確搜索結(jié)果
- Products
- Applications and Industries
- 內(nèi)容類型
- Analysis Platform
- 語言
21 - 40 共 113 條結(jié)果
應(yīng)用的篩選條件
安捷倫 Seahorse 細(xì)胞能量代謝主題線上研討會
從分析級到制備級應(yīng)用，Agilent AdvanceBio 寡核苷酸色譜柱、軟件和儀器都可以無縫配合，大幅減少方法優(yōu)化和停機時間。
在抗體藥物開發(fā)的早期研發(fā)、臨床前研究、CMC質(zhì)量控制和臨床研究等不同階段都涉及多種類型的生物學(xué)活性測定，目前基于細(xì)胞分析的體外生物學(xué)活性評價方法具有操作便捷、特異性好、可重復(fù)性高、通量高等優(yōu)勢，因此在抗體開發(fā)流程中得到廣泛的應(yīng)用，安捷倫的細(xì)胞分析相關(guān)產(chǎn)品能夠從多維度的應(yīng)用角度，提供全面而靈活的體外抗...
為 Agilent NovoCyte Opteon 光譜流式細(xì)胞儀設(shè)計了 45 色光譜流式細(xì)胞技術(shù)配色方案，用于分析外周血單核細(xì)胞 (PBMC) 樣品中免疫細(xì)胞的分布。
使用標(biāo)準(zhǔn)化 LC/TQ 平臺優(yōu)化您的靶向組學(xué)。我們先進(jìn)的 LC/TQ 技術(shù)可為主要代謝物、脂質(zhì)和多肽創(chuàng)建龐大的多重目標(biāo)物列表。
隨著生物學(xué)、醫(yī)學(xué)和藥學(xué)研究范式的不斷迭代更新，當(dāng)下基因編輯、細(xì)胞重編程、高通量篩選、生物新型材料開發(fā)、3D 打印等新技術(shù)層出不窮，而類器官作為承載以上技術(shù)的體外模式工具在近幾年得到突飛猛進(jìn)的發(fā)展。類器官是指利用成體干細(xì)胞（ASC）或多能干細(xì)胞(PSC)進(jìn)行體外三維(3D)培養(yǎng)而形成的具有一定空間結(jié)構(gòu)...
本文以 Agilent 1290 Infinity II 二元泵混搭 Agilent 1260 Infinity II 自動進(jìn)樣器為例，詳細(xì)介紹了硬件調(diào)整方式和方法設(shè)置具體參數(shù)。經(jīng)過優(yōu)化調(diào)整后，能夠在 0.7 min 內(nèi)完成單針進(jìn)樣分析。
本文介紹了一種利用 Agilent 1260 Infinity II Prime 液相色譜系統(tǒng)，Agilent 1290 Infinity II ELSD 檢測器和 Poroshell 120 CS-C18 色譜柱 (3.0 mm × 100 mm, 2.7 μm) 檢測細(xì)胞基因治療慢病毒原液中轉(zhuǎn)染...
This document highlights the technical details and configurations of the Agilent BioTek Epoch 2 microplate spectrophotometer.
This document highlights the technical details and configurations of the Agilent BioTek Synergy H1 multimode reader.
CAR T-cell manufacturing conditions are critical to differentiation, metabolic fitness, and cytotoxic function, enhancing therapy efficacy and production efficiency.
This poster reveals to optimize T-cell differentiation in bioreactors using integrated Agilent cell analytics and feedback control to enhance CAR T-cell therapyproduction.
Describes use of a tethering approach to immobilize liquid tumor cell lines on to the surface of gold biosensors embedded in an Agilent E-Plate.
User manual for the Seahorse XF 3D Mito Stress Test Assay.
Demonstration of the wide range of metabolic rates that can be quantified on the Agilent Seahorse XF Flex analyzer through the use of different Seahorse XF microplates and in vitro differentiation of adipocytes.
TGF-β/SMAD signaling is quantitatively evaluated in biochemical, cellular, and spheroid-based assays using a cancer model of epithelial-to-mesenchymal transition.
Protocol for SureSelect Max Fast Hybridization for target enrichment of DNA libraries for MGI NGS.
Protocol for SureSelect Max DNA Library Preparation using Enzymatic Fragmentation for MGI multiplexed sequencing.
Protocol for SureSelect Max DNA Library Preparation using Covaris-sheared DNA for MGI multiplexed sequencing.
SureSelect Max DNA Library Prep and Target Enrichment, Automated using Agilent Bravo NGS Workstation (Option B), With Enzymatic Fragmentation, For Illumina Platform NGS